fda semaglutide mash Gets Greenlight for FDA Approves Semaglutide to Treat
Description
What is the efficacy of oral semaglutide (3, 7, or 14 mg/d) compared with sitagliptin, 100 mg/d, when added to metformin with or without sulfonylurea in patients with uncontrolled type 2 diabetes

This exclusive discount is available only to Military.com readers
:max_bytes(150000):strip_icc()/VWH-Wegovy-receives-FDA-approval-for-treating-MASH-51d3bd1a89894b5e80b8a1a093d30a63.jpg)
Semaglutide can lower blood pressure through weight loss and direct cardiovascular effects, but individual responses vary significantly

Thats a drastic change and may feel like a shock to the system

Explore Blue Cross Blue Shield's coverage for weight loss medication on DripToYou

Here's what the final numbers reveal about the future of metabolic therapy.